AGP Picks
View all

The Asia Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Gazette.

Press releases published on August 4, 2026

PN Smart Energy Limited Reports First Half 2026 Financial Results
Bitdeer Announces $4.7 Billion, 16-Year AI/HPC Data Center Lease for Tydal, Norway Campus
Leads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases
Connecting the World to New Opportunities - Guangzhou Nansha Builds a New Ecosystem for Cross-Border Trade
Borderless Tech Launches Space Pick, an Interactive Floor Plan Booking Platform, as It Expands into Hong Kong, Canada, and North America
YY Group Acquires 95% Stake in Profitable Singapore-Incorporated Distributor
DEEP SEA MINERALS CORP. FILES FORM F-10 REGISTRATION STATEMENT WITH U.S. SECURITIES AND EXCHANGE COMMISSION BECOMING A U.S. REPORTING COMPANY
NIOB cuts target pegmatite in all Bardy holes
LEPAS Builds New Momentum in July, Advancing Global NEV Expansion
IREN Completes Acquisition of Mirantis
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
Senmiao Technology Limited Engages Strategic Advisory Firm to Support Government Relations and Strategic Advisory Efforts
Yili Group Drives Innovation and Collaboration for a Sustainable Global Dairy Ecosystem at the 2026 World Dairy Congress
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Asia Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.